Key market players operating in addiction treatment market are focusing on developing strategies to mitigate the usage of opioids along with enhancing their operations to serve the evolving needs of the consumer. Those strategies encompass acquisitions, partnerships and the opening of new facilities, aim to widen the target patient segment with expanded service offerings. Furthermore, companies are focusing on R&D to devise novel treatment approaches, including digital therapeutics, telemedicine software, and personalized care models to maximize treatment outcomes and patient adherence. In addition, a continuous focus on evidence-based practices, quality standards and patient care models will be required to prove that system is safe, effective and compliant to regulations, which will lead to a patient and stakeholder trust and loyalty. 'Alkermes plc (Ireland) ', 'Dr. Reddy’s Laboratories Ltd. (India) ', 'Hikma Pharmaceuticals plc (UK) ', 'Indivior PLC (UK) ', 'Mallinckrodt Pharmaceuticals (Ireland) ', 'Orexo AB (Sweden) ', 'Pear Therapeutics (US) Inc. (US) ', 'Pfizer Inc. (US) ', 'Viatris Inc. (US) ', 'American Addiction Centers, Inc. (US) ', 'Quest Diagnostics, Inc. (US) ', 'Sage Therapeutics, Inc. (US) ', 'Gilead Sciences, Inc. (US) ', 'Acadia Pharmaceuticals Inc. (US) ', 'Medications for Addiction Treatment (MAT) (US) ', 'Intra-Cellular Therapies, Inc. (US) ', 'Emergent BioSolutions Inc. (US) ', 'Hims & Hers Health, Inc. (US) ', 'Lundbeck A/S (Denmark) ', 'Cambrex Corporation (US) ', 'Caron Treatment Centers (US) ', 'Smart Recovery (US) ', 'Recovery Brands (US)', 'In May 2023, Camurus AB, a Swedish science-driven biopharma company, announced that Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) was approved by the U.S. Food and Drug Administration for the treatment of moderate to severe opioid use disorder (OUD). ', 'On May 14, 2024, Lifespan Health System announced a new addiction treatment program aiming to provide same-day assistance to patients. It's called Addiction Care Today, and it aims to provide walk-in and same-day appointments to people seeking to start treatment for substance use disorders. ', 'In February 2024, Union Council of Ministers had announced that they had launched 41 dedicated addiction treatment facilities for drug addicts in Delhi. These facilities will free of cost treat, counsel and provide free medicines to the people who are addicted to drugs or other substances.'